The Endocrine Society's Guidelines for the Pharmacologic Management of Obesity, advises clinicians to target obesity first in order to mitigate or eliminate its related comorbidities and complications including type 2 diabetes, dyslipidemia, and hypertension, rather than aiming first to treat the comorbidities caused by the excess weight -- Treat Weight First.

The Endocrine Society engaged four health care practitioners -- an internist, a family practice physician, an osteopathic practitioner, and a nurse practitioner -- in a pilot program to collaborate with faculty on the Guidelines on Pharmacologic Management of Obesity to develop a curriculum for primary care practitioners in obesity medical management best practices. The goal was to encourage primary care practitioners to treat weight first, rather than treating co-morbidities without directly addressing weight as a factor in overall health. Review the outcomes of the Weight First initiative 2016 pilot here.

The objective of the Weight First initiative 2016 pilot was to demonstrate that an obesity curriculum co-developed by endocrinologists and primary care practitioners overcomes barriers to the effective management of patients with obesity. The curriculum covered three key elements of obesity medical management:

  1. Motivational interviewing
  2. Therapeutic options for treating obesity
  3. Reimbursement


The three phases of the pilot were:

  1. Three Endocrine Society faculty and four primary care leaders from Louisiana and nearby states will collaborate on a comprehensive obesity medical management presentation.
  2. The four primary care leaders, then, make their own presentations to their colleagues at their respective state chapter annual meetings.
  3. Any clinicians interested in improving care for their patients can view the core curriculum on this site and earn AMA PRA Category 1 CME credits through the Endocrine Society.
Weight First pilot 3 step plan


The Goal: Better health through obesity management


The 2016 Weight First initiative pilot was a medical education collaboration between the Endocrine Society and:


This pilot was developed by Knighten Health and supported by an education grant from Novo Nordisk Inc.